NRx Pharmaceuticals (NRXP) Institutional Ownership → Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad) Free NRXP Stock Alerts $3.12 +0.10 (+3.31%) (As of 12:08 PM ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for NRx Pharmaceuticals (NASDAQ:NRXP)CurrentInstitutional OwnershipPercentage4.27%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$47.34MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$16.29M Get NRXP Insider Trade Alerts Want to know when executives and insiders are buying or selling NRx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NRXP Institutional Buying and Selling by Quarter Ad Paradigm PressBitcoin Rockets To Record High But Buy THIS InsteadRecently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. NRx Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/15/2024Bridgeway Capital Management LLC122,700$56K0.0%-23.6%0.144% 2/14/2024AdvisorShares Investments LLC642,632$296K0.1%N/A0.755% 1/25/2024One Wealth Management Investment & Advisory Services LLC140,402$65K0.0%N/A0.165% 12/18/2023Vanguard Group Inc.1,450,593$377K0.0%-1.9%1.703% 11/15/2023Sabby Management LLC325,000$84K0.1%-53.6%0.398% 8/15/2023Royal Bank of Canada171,233$83K0.0%+135,799.2%0.239% Get the Latest News and Ratings for NRXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/11/2023BlackRock Inc.290,714$141K0.0%-22.5%0.406% 5/1/2023Virtu Financial LLC46,210$30K0.0%N/A0.065% 2/13/2023Charles Schwab Investment Management Inc.43,732$49K0.0%N/A0.065% 2/13/2023Geode Capital Management LLC378,667$420K0.0%+18.1%0.559% 2/10/2023Bank of America Corp DE35,809$40K0.0%+10,884.4%0.053% 2/10/2023HRT Financial LP26,501$29K0.0%N/A0.039% 2/9/2023HBK Sorce Advisory LLC58,460$65K0.0%N/A0.086% 1/31/2023AE Wealth Management LLC29,515$33K0.0%N/A0.044% 1/27/2023Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040% 1/18/2023Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040% 11/15/2022Vanguard Group Inc.1,440,265$1.07M0.0%+31.6%2.129% 11/3/2022Texas Capital Bank Wealth Management Services Inc.63,290$47K0.0%N/A0.094% 8/15/2022Millennium Management LLC296,815$178K0.0%N/A0.445% 5/18/2022Ursa Fund Management LLC15,000$37K0.0%N/A0.023% 5/16/2022State Street Corp114,240$280K0.0%+1,009.1%0.171% 5/13/2022Renaissance Technologies LLC139,003$341K0.0%N/A0.209% 5/13/2022Northern Trust Corp58,598$144K0.0%+61.5%0.088% 5/13/2022Vanguard Group Inc.1,075,317$2.63M0.0%-8.3%1.614% 5/12/2022BlackRock Inc.525,493$1.29M0.0%+1.9%0.789% 5/12/2022Citigroup Inc.15,208$37K0.0%+355.1%0.023% 5/11/2022Bank of New York Mellon Corp10,129$25K0.0%N/A0.015% 4/29/2022United Asset Strategies Inc.18,300$45K0.0%N/A0.027% 2/9/2022Wolverine Asset Management LLC37,105$177K0.0%-12.8%0.063% 2/8/2022Raymond James Financial Services Advisors Inc.11,567$55K0.0%N/A0.020% 11/15/2021Penserra Capital Management LLC2,956$27K0.0%N/A0.005% 11/12/2021Wolverine Asset Management LLC42,568$394K0.0%+118.4%0.079% 11/5/2021Advisor Group Holdings Inc.42,885$398K0.0%+1,197.6%0.080% 11/2/2021Cambridge Investment Research Advisors Inc.153,523$1.42M0.0%N/A0.285% 8/16/2021Owl Creek Asset Management L.P.300,000$3.40M0.2%N/A0.626% 8/16/2021Ionic Capital Management LLC35,721$415K0.0%N/A0.075% 8/16/2021Linden Advisors LP364,352$4.23M0.0%N/A0.760% 8/13/2021Northern Trust Corp130,633$1.52M0.0%N/A0.273% 8/13/2021Yakira Capital Management Inc.11,923$139K0.0%N/A0.025% 8/13/2021Geode Capital Management LLC34,475$400K0.0%N/A0.072% Bitcoin Rockets To Record High But Buy THIS Instead (Ad)Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is.8/13/2021Vanguard Group Inc.637,416$7.41M0.0%N/A1.330% (Data available from 1/1/2016 forward) NRXP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NRXP shares? During the previous two years, 24 institutional investors and hedge funds held shares of NRx Pharmaceuticals. The most heavily invested institutionals were Geode Capital Management LLC ($420K), Vanguard Group Inc. ($377K), Renaissance Technologies LLC ($341K), AdvisorShares Investments LLC ($296K), State Street Corp ($280K), Millennium Management LLC ($178K), and Northern Trust Corp ($144K).Learn more on NRXP's institutional investors. What percentage of NRx Pharmaceuticals stock is owned by institutional investors? 4.27% of NRx Pharmaceuticals stock is owned by institutional investors. Learn more on NRXP's institutional investor holdings. Which institutional investors have been buying NRx Pharmaceuticals stock? Of the 22 institutional investors that purchased NRx Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AdvisorShares Investments LLC ($642.63K), Vanguard Group Inc. ($345.55K), Millennium Management LLC ($296.82K), Royal Bank of Canada ($171.11K), One Wealth Management Investment & Advisory Services LLC ($140.40K), Renaissance Technologies LLC ($139.00K), and State Street Corp ($103.94K). How much institutional buying is happening at NRx Pharmaceuticals? Institutional investors have bought a total of 2,320,988 shares in the last 24 months. This purchase volume represents approximately $207.97M in transactions. Which NRx Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold NRx Pharmaceuticals stock in the last 24 months: Sabby Management LLC ($374.73K), Vanguard Group Inc. ($124.48K), BlackRock Inc. ($84.53K), and Bridgeway Capital Management LLC ($38K). How much institutional selling is happening at NRx Pharmaceuticals? Institutional investors have sold a total of 621,740 shares in the last 24 months. This volume of shares sold represents approximately $40.04M in transactions. Related Companies: Bolt Biotherapeutics Major Shareholders Apollomics Major Shareholders Clene Major Shareholders CalciMedica Major Shareholders Rockwell Medical Major Shareholders BioLineRx Major Shareholders Daré Bioscience Major Shareholders ProMIS Neurosciences Major Shareholders Aadi Bioscience Major Shareholders Ocuphire Pharma Major Shareholders This page (NASDAQ:NRXP) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIThe #1 Crypto for 2024InvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsUrgent alert: open this for a huge profit potentialTimothy Sykes1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.